Beskrywing

DNA sequencing is a laboratory technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes. A study by StrategyHelix indicates that the global DNA sequencing market is expected to increase by US$ 28.7 miljard van 2022 aan 2028, 'n CAGR van 18.1% gedurende die voorspellingsperiode.

Die verslag verskaf up-to-date markgrootte data vir tydperk 2018-2021 en voorspel tot 2028 covering key market aspects like sales value for DNA sequencing. The global DNA sequencing market is segmented on the basis of product, sequencing type, aansoek, en streek. Gebaseer op produk, the global DNA sequencing market is categorized into sequencing services, sequencing instruments, sequencing consumables, sequencing informatics. Sequencing services held the highest share in the global dna sequencing market. Egter, the sequencing informatics segment is forecast to register the highest CAGR during the forecast period 2022 – 2028. On the basis of sequencing type, the global DNA sequencing market has been segmented into next generation sequencing (NGS), sanger sequencing, ander. The NGS segment captured the largest share of the market in 2021. Deur aansoek, the global DNA sequencing market has been segmented into applied, clinical, navorsing. In terms of geography, the global DNA sequencing market has been segmented into Asia Pacific, Europa, Noord-Amerika, Rest of the World (RoW). North America held the largest revenue share in 2021.

The global DNA sequencing market is highly competitive. Asof 2021, the major players in the global DNA sequencing market were Adaptive Biotechnologies Corp., Agilent Technologies Inc., Ambry Genetics Corporation, BD (Becton Dickinson and Company), Berry Genomics Co. Bpk., BGI Group, Biodesix Inc., CareDx Inc., Centogene AG, Danaher Corporation, Devyser Diagnostics AB, Illumina Inc., Macrogen Inc., Merck KGaA, myDNA Inc., Natera Inc., NeoGenomics Laboratories Inc., New England Biolabs Inc., NGeneBio Co. Bpk., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., Qiagen N.V., Quest Diagnostics Inc., Roche Holding AG, SOPHiA GENETICS, TAKARA BIO INC., Thermo Fisher Scientific Inc.

Die verslag is 'n waardevolle hulpbron vir maatskappye en organisasies wat in hierdie bedryf aktief is. It provides a cohesive picture of the DNA sequencing market to help drive informed decision making for industry executives, beleidmakers, akademies, en ontleders.

Verslag Omvang

Produk: sequencing services, sequencing instruments, sequencing consumables, sequencing informatics
Sequencing type: next generation sequencing (NGS), sanger sequencing, ander
Toepassing: applied, clinical, navorsing
Streek: Asiatiese Stille-Oseaan, Europa, Noord-Amerika, Rest of the World (RoW)
Jare oorweeg: hierdie verslag dek die tydperk 2018 aan 2028

Sleutelvoordele vir belanghebbendes

– Get a comprehensive picture of the global DNA sequencing market
– Bepaal groeisektore en -neigings vir belegging

INHOUDSOPGAWE

Deel 1. Inleiding
– Omvang van die studie
– Studietydperk
– Geografiese omvang
– Navorsingsmetodologie
Deel 2. DNA sequencing market overview
Deel 3. Market breakdown by product
– Sequencing services
– Sequencing instruments
– Sequencing consumables
– Sequencing informatics
Deel 4. Market breakdown by sequencing type
– Next generation sequencing (NGS)
– Sanger sequencing
– Ander
Deel 5. Markverdeling volgens toepassing
– Applied
– Clinical
– Research
Deel 6. Market breakdown by region
– Asiatiese Stille-Oseaan
– Europa
– Noord-Amerika
– Rest of the World (RoW)
Deel 7. Sleutel maatskappye
– Adaptive Biotechnologies Corp.
– Agilent Technologies, Inc.
– Ambry Genetics Corporation
– BD (Becton, Dickinson and Company)
– Berry Genomics Co., Bpk.
– BGI Group
– Biodesix, Inc.
– CareDx, Inc.
– Centogene AG
– Danaher Corporation
– Devyser Diagnostics AB
– Illumina, Inc.
– Macrogen, Inc.
– Merck KGaA
– myDNA Inc.
– Natera, Inc.
– NeoGenomics Laboratories, Inc.
– New England Biolabs, Inc.
– NGeneBio Co., Bpk.
– Oxford Nanopore Technologies Limited
– Pacific Biosciences of California, Inc.
– PerkinElmer, Inc.
– Personalis, Inc.
– Qiagen N.V.
– Quest Diagnostics Inc.
– Roche Holding AG
– SOPHiA GENETICS
– TAKARA BIO INC.
– Thermo Fisher Scientific Inc.
Oor StrategyHelix
Vrywaring